High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria

Journal of Inherited Metabolic Disease

Volumn 36, Issue 6, 2013, Pages 1063-1071

  Sardh, Eliane ^a,b   Wahlin, Staffan ^b   Björnstedt, Mikael ^b   Harper, Pauline ^b   Andersson, Dan E H ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER INCIDENCE; CANCER RISK; CHEMOEMBOLIZATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATIC PORPHYRIA; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL TIME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORPHOBILINOGEN SYNTHASE; PORPHYRIAS, HEPATIC; RISK FACTORS; SURVIVAL ANALYSIS; SWEDEN;

EID: 84888206536     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-012-9576-9     Document Type: Article

References (29)

1. Andant C, Puy H, Bogard C et al (2000) Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 32(6):933-939
2. Anderson KE, Sassa S, Bishop DF, Desnick RJ (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. The metabolic and molecular bases of inherited disease. In: Scriver CR, Beaudet AL, Sly WS and Valle D (eds) McGraw-Hill, New York 2: 2991-3062
3. Andersson C, Bjersing L, Lithner F (1996) The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med 240:195-201
4. Batlle AM (1993) Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J Photochem Photobiol B Biol 20:5-22
5. Bengtsson NO, Hardell L (1986) Porphyrias, porphyrins and hepatocellular cancer. Br J Cancer 54:115-117
6. Bjersing L, Andersson C, Lithner F (1996) Hepatocellular carcinoma in patients from Northern Sweden with acute intermittent porphyria: morphology and mutations. Cancer Epidemiol Biomarkers Prev 5:393-397
7. Bosch FX, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. J Gastroenterol 127(5):S5-S16
8. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208-1236
9. Deybach JC, Puy H (2011) Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa. J Intern Med 269(5):521-524
10. Floderus Y, Shoolingin-Jordan P, Harper P (2002) Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene. Clin Genet 62(4):288-297
11. Hardell L, Bengtsson NO, Jonsson U, Eriksson S, Larsson LG (1984) Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation. Br J Cancer 50:389-397
12. Harper P, Wahlin S (2007) Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria. Curr Treat Options Gastroenterol 10(6):444-455
13. Innala E, Andersson C (2011) Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med 269(5):538-545
14. Kauppinen R, Mustajoki P (1988) Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 57:117-120
15. Kauppinen R, Mustajoki P (1992) Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine 71:1-13
16. Kauppinen R, von und zu Fraunberg M (2002) Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Clin Chem 48(11):1891-1900
17. Leong TY, Leong AS (2005) Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB (Oxford) 7(1):5-15
18. Lindstedt G, Nillroth LW, von Schéele C, Schelin U, Swolin B, Zettergren L (1973) [Late first appearance of porphyria in a patient with primary liver cancer] Sen debut av porfyri hos en patient med primär levercancer. Lakartidningen 70(47):4265-4266
19. Lithner F, Wetterberg L (1984) Hepatocelluar carcinoma in patients with acute intermittent porphyria. Acta Med Scand 215:271-274
20. Onuki J, Teixeira PC, Medeiros MH et al (2002) Is 5-aminolevulinic acid involved in the hepatocellular carcinogenesis of acute intermittent porphyria? Cell Mol Biol (Noisy-le-grand) 48(1):17-26
21. Ostrowski J, Kostrzewska E, Michalak T, Zawirska B, Medrzejewski W, Gregor A (1983) Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias. Gastroenterology 85:1131-1137
22. Schneider-Yin X, Van Tuyll van Serooskerken AM, Went P et al (2010) Hepatocellular carcinoma in variegate porphyria: a serious complication. Acta Derm Venereol 90(5):512-515
23. Seth AK, Badminton MN, Mirza D, Russell S, Elias E (2007) Liver transplantation for porphyria: who, when, and how? Liver Transpl 13(9):1219-1227
24. Soonawalla ZF, Orug T, Badminton MN et al (2004) Liver transplantation as a cure for acute intermittent porphyria. Lancet 363(9410):705-706
25. Stojeba N, Meyer C, Jeanpierre C et al (2004) Recovery from a variegate porphyria by a liver transplantation. Liver Transpl 10(7):935-938
26. Thunell S, Andersson C, Carlmark B et al (1995) Markers for vulnerability in acute porphyria. A hypothesis paper. Eur J Clin Chem Clin Biochem 33:179-194
27. Thunell S, Floderus Y, Henrichson A, Harper P (2006) Porphyria in Sweden. Physiol Res 55(Suppl 2):S109-S118
28. Wahlin S, Harper P, Sardh E, Andersson C, Andersson DE, Ericzon BG (2010) Combined liver and kidney transplantation in acute intermittent porphyria. Transpl Int 23(6):e18-e21
29. Wiman Å (2003) Genetic Characterization of Swedish Families with Hereditary Coproporphyria, Variegate Porphyria, and Erythropoietic Protoporphyria. Dep Med Lab Sci and Tech, Div Clin Chem, Karolinska Institutet, Huddinge Univ Hospital. Stockholm, Karolinska Institutet